Navigating Private Equity Buyouts: A Guide for Plastic Surgeons at All Career Stages

应对私募股权收购:整形外科医生在各个职业阶段的指南

阅读:1

Abstract

BACKGROUND: Recently, private equity (PE) investments in plastic surgery have increased as senior surgeons retire and transfer their legacy practices to corporate ownership in exchange for substantial payouts. During this transition, clinicians and practitioners at acquired practices often feel skeptical about the organization's goals and future. If left unaligned, the relationship between these groups deteriorates, and consequently, so does the quality of clinical care. Although the medical literature on this topic highlights the risks of PE, it often fails to address strategies for fostering a healthy working relationship among these groups. METHODS: A comprehensive review of the medical business management literature was conducted to identify potential solutions applicable to clinical settings. RESULTS: PE acquisitions typically give rise to 5 core concerns: future uncertainty, salary cuts or job losses, increased workloads, loss of clinical autonomy, and unclear organizational and career prospects. This article identifies recommendations tailored to both clinicians and PE leaders to improve integration, alignment, and productive partnerships. These recommendations address the unique concerns and aspirations of physicians at various stages of their careers within the PE landscape, with the overarching goal of enhancing practice valuation and achieving career success without compromising patient care. CONCLUSIONS: Drawing insights from business management, this article proposes actionable steps to improve the integration of PE firms into plastic surgery practices. A collaborative partnership can benefit all stakeholders-physicians, practices, PE investors, and patients-while safeguarding the quality of patient care.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。